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Anti-human Hsp60 autoantibodies – known risk factor of atherosclerosis – were investigated in a mouse model and 
in samples of healthy subjects: polyreactivity, presence in cord blood samples of healthy newborns and life-long 
stability were tested. In IgM hybridoma panel from mouse spleens, polyreactivity of anti-Hsp60 autoantibodies was 
studied. In healthy pregnant women, umbilical vein and maternal blood samples were collected after childbirth, anti-
Hsp-60 and -65 IgM and IgG levels were measured. Life-long stability of anti-Hsp-60 levels was studied on healthy 
patients during 5 years. ELISA was used in all studies. Polyreactivity of IgM clones of newborn mice and lifelong 
stability of these autoantibodies in healthy adults were established. IgM anti-Hsp60 autoantibodies in cord blood 
of healthy human infants were present, however, there was no correlation between maternal and cord blood IgM 
anti-Hsp60 concentrations. It is proposed that presence of anti-Hsp60 autoantibodies – as part of the natural 
autoantibody repertoire – may be an inherited trait. Level of anti-Hsp60 autoantibodies may be an independent, 
innate risk factor of atherosclerosis for the adulthood.
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Natural antibodies refer to antibodies that are present in the serum of healthy individuals 
without overt immunization or infection (1). The importance of natural antibodies reacting 
with self-antigens (natural autoantibodies) received more attention recently (2).
Natural autoantibodies, autoreactive B- and T-cells are present in healthy individuals and 
are referred to as part of the predominantly selected autoreactive repertoires of the healthy 
immune system (1).
Heat shock proteins are functionally and immunologically highly conserved molecules 
present in almost all living organisms (3, 4). Bacterial and human Hsp share considerable 
homology (5) and antibodies or T-cells that recognize microbial Hsp as immunodominant 
antigens often cross-react with human Hsp (6). Anti-60 kD heat shock protein (Hsp60) 
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antibodies are indeed present in serum of healthy human subjects (7, 8) and also in samples 
of patients with different diseases incuding atrial fibrillation (9), atherosclerosis (10) and 
including different forms of vascular diseases (11). The presence of anti-Hsp60 autoantibodies 
in these diseases is considered as the sign of infection induced autoimmunity (12).
However, van Eden and colleagues (13) and Cohen and c-young (6) formulated 
alternative hypotheses to explain the presence of self-Hsp reacting antibodies and T-cells. 
Besides induction through mimicry mechanism, according to their explanation, anti-self Hsp 
autoreactivity may be the integral part of the normal immune function with a role in self-
protecting, regulating autoimmunity. Basic features of self-protecting, natural autoantibodies 
include polyreactivity, life-long stability, connectivity, presence in samples of newborn 
animals without antigenic stimulation (indicating germ-line encoding) and low affinity 
(14). In humans natural autoantibodies may belong to IgG, IgM and IgA isotypes with the 
predominance of IgG, whereas in mice IgM autoantibodies dominate (14, 15). Previous 
work indicated that a certain class of autoantibodies, i.e. anti-Hsp autoantibodies, may play 
significant role in self-protecting autoimmunity (6).
Published evidences indicate important roles for anti-Hsp60 autoantibodies in the 
pathogenesis of atherosclerosis. The association of elevated anti-Hsp60 levels with different 
vascular diseases was repeatedly shown (11), and their clinical importance was also indicated 
by results of prospective studies (16, 17). Most importantly, the causal pathogenic role of anti-
Hsp60 antibodies has been shown by Mandal and associates (18) by showing that anti-Hsp60 
antibodies purified from sera of patients with documented atherosclerosis when injected into 
tail vein of apoE deficient mice resulted in accelerated atherosclerosis in them. Some earlier 
observations of our group, including the description of anti-Hsp60 reactivity independently 
of common bacterial infections (19); the stability of anti-Hsp60 autoantibody titers over 
long observation periods (8); and the lack of elevation of anti-Hsp60 IgG in certain diseases 
characterized by polyclonal B-cell activation (8) supported the view Hsp60 autoantibodies 
might belong to the group of natural autoantibodies. Therefore, in the present study we aimed 
at carrying out an in-depth analysis of anti-Hsp60 autoantibodies to investigate whether 
they carry some characteristics of natural autoantibodies and whether they are part of the 
innate immune system. To achieve this goal the following parameters were investigated: 
polyreactivity and presence in cord blood samples of healthy newborns. 
Methods
Mouse IgM hybridoma panel
The establishment of the IgM hybridoma panel from spleens of healthy newborn balb/c mice 
consisting of 26 different clones was described earlier (20). Supernatants stored at –20ºC 
were used in our experiments. The investigation conforms with the Guide for the Care and 
Use of Laboratory Animals published by the US National Institutes of Health.
Maternal and cord blood samples
Following informed consent 51 healthy pregnant women after complication-free pregnancies 
took part in the study, which was approved by the Ethical Committee and was carried out 
in accordance with the Declaration of Helsinki. The mean age of the mothers at delivery 
was 28 years (range, 20–41 yrs). Sera were separated from two blood samples, one taken 
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from the placental part of the umbilical vein and the other taken from the antecubital vein of 
mothers within 12 hours after complication-free childbirth, and were stored at –70°C until 
processing.
Healthy adult men
The Second Northwick Park Heart Study has been described previously (21). The 4600 men 
50–61 years registered in 9 medical practices in Great Britain were screened for eligibility 
for the study. Exclusion criteria were: a history of unstable angina or acute myocardial 
infarction (AMI); a major Q wave on the electrocardiogram (ECG); regular anti-platelet 
or anticoagulant therapy; cerebrovascular disease; life-threatening malignancy; history of 
hepatitis B or other infectious disease; diabetes; high blood pressure (BP); kidney and liver 
problems; high cholesterol or thyroid problems at baseline; angina pectoris at any follow up, 
or precluding informed consent. Forty-eight from those who remained disease-free during 
follow-up (5 years) were randomly selected for this study and stored serum samples obtained 
in three points of time (baseline, after 3 years and after 5 years) were provided.
Analytical measurements
The amounts of IgG-type antibodies reacting with proteins of the Hsp 60 family [recombinant 
human hsp60 (StressGen, SPP-740, Victoria, Canada); recombinant M. bovis hsp65 (batch 
MA14, GBF, Braunschweig, Germany, supported by the UNDP/World Bank/WHO Special 
Program for Research and Training in Tropical Diseases)] were assessed by ELISA as 
described previously (8).
In brief, plates were coated with 0.1 μg/well human hsp60 or M. bovis hsp65. After 
washing and blocking (PBS, 0.5% gelatin) the wells were incubated with 100 μL of serum 
samples diluted 1:500 in PBS containing 0.5% gelatin and 0.05% Tween 20. Binding of anti-
hsp antibodies was determined using γ-chain specific anti-human IgG peroxidase labeled 
antibodies (Sigma, St. Louis, USA) and an O-phenylene-diamine (SIGMA) detection system. 
The optical density was measured at 490 nm (reference at 620 nm) and the means of duplicate 
wells were calculated after subtraction of OD registered in uncoated wells. A serial dilution 
of a high-reacting human serum was used as standard. Data obtained as optical density values 
were calculated to arbitrary unit/mL values related to this standard. 
Measurement of IgM type anti-hsp60 was done on plates coated with 5 μg/ml human 
hsp60 or M. Bovis Hsp65. Incubation with the sample was done at 4 °C over night, and the 
wells were developed with rabbit anti-human-IgM-POX and anti-rabbit-IgG-POX-conjugates 
together to amplify the specific reaction. Since there were no available high-titer serum 
samples to be used as standard results are indicated as OD values. Each measurement was 
done on one particular day, using two ELISA plates, and there was no significant plate to plate 
variability thus there was no need to normalize the data. Means of duplicate measurements 
were calculated after subtraction of background. Samples of adults or newborns were diluted 
1:400 or 1:20, respectively, in the anti-Hsp60/65 assays. 
Total IgG and IgM levels were determined by sandwich-type ELISA. Plates were coated 
with mouse anti-human IgG or IgM antibodies, incubated with test samples and developed 
with rabbit anti-human IgG and IgM peroxidase conjugates following incubation. Purified 
human IgG and IgM were used as standards.
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Statistical analysis
As the variable antibody to heat shock proteins was not normally distributed, non-parametric 
tests were used for group comparisons, and Spearman rank correlation coefficients were 
calculated for estimating interrelations between anti-Hsp antibodies and other variables. The 
significance level was set at the value of p< 0.05. Non-parametric values are presented as 
median (25th – 75th percentile), parametric values as mean ± standard deviation. 
Results
Polyreactivity of anti-Hsp60 autoantibodies
Twenty-six IgM hybridoma clones from newborn healthy mice were tested for their reactivity 
against Hsp60. These clones have earlier been tested for their reactivity towards haptens and 
common autoantigens (20). Table I presents the results of our Hsp60 reactivity measurements 
together with previous findings. Five out of the 26 clones were shown to react with human 
Hsp60 and these clones were reactive against at least 4 antigens out of the 6 investigated. 
Two out of these 5 clones were even reacting with all the 6 antigens tested. It is important to 
note, that there are no sequence homologies or functional similarities between the analyzed 
antigens and Hsp60 (two antigens belong to haptens). 
Presence of IgM anti-Hsp60 antibodies in cord blood samples of healthy newborns
Blood samples of 51 healthy newborns and their mothers were investigated for the presence 
of IgG and IgM type antibodies reacting with human and M. bovis Hsp60-family proteins 
in this ethical-committee approved consecutive study. The median age of the mothers was 
28 ± 4.8 (±SD) years (range 20-41 years). Only women with complication-free pregnancies 
were included in our study; 45% of the population never smoked, 42% smoked beforehand, 
and 13% smoked during pregnancy. Mothers gave birth to healthy, mature newborns (each 
singlet, 51% girls). 
Results of anti-Hsp60 and anti-Hsp65 measurements are presented in Figure 1. Median 
of total IgG concentration in the maternal samples was 8.17 g/l (IQ range 6.7-9.54) and in 
cord blood samples 9.93 g/l (8.61–11.8). Total IgM levels were as follows: 1.56 g/l (0.86-
2.2, maternal samples) and 0.073 g/l (0.056–0.103, for newborns). These concentrations fall 
within the age-adjusted reference ranges of the two groups. 
Both IgG and IgM anti-Hsp60 specific autoantibodies were present in all cord blood 
and maternal samples. In contrast, only IgG anti-Hsp65 antibodies were detected in all 
samples; IgM anti-Hsp65 antibodies were absent from maternal samples and only 9/51 (18%) 
of the cord blood samples showed reactivity towards Hsp65. Whereas highly significant 
correlation between maternal and cord blood IgG anti-Hsp60 levels was observed (r=0.901; 
p<0.0001), there was no similar correlation between maternal and cord blood IgM anti-Hsp60 
concentrations (r=0.03; p=0.823).
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Table I Reactivity pattern of an IgM monoclonal antibody panel of healthy newborn mice  
with certain haptens and antigens*
Clone TNP-BSA FITC-BSA BSA DNS Actin Hsp60 # of positive
1/1 3
1/4 3
1/5 4
1/11 3
2/3 5
2/5 3
2/13 4
2/15 3
2/21 4
3/9 4
3/17 5
3/25 2
4/5 2
4/6 4
4/12 2
4/20 1
4/21 6
6/17 2
6/26 4
6/34 5
7/1 2
7/8 3
7/16 4
7/20 5
8/8 6
8/14 4
* The antibody reactivity is indicated by the highest dilution giving an OD>0.1 on the gray-scale; black: 1:400; dark 
gray 1:100; gray 1:20; white: OD<0.1 in all dilutions. TNP: 2,4,6 trinitrophenyl; FITC: fluorescein isothyocianate, 
BSA: bovin serum albumin
Table II Changes of anti-Hsp60 autoantibody levels during 5 years of follow up in healthy men
Baseline Third year Fifth year
Sample
Anti-Hsp60 (AU/ml, n=48) 62.4 (32.9–99.5)* 53.5 (35.2–84.3)* 51.6 (31.8–97.1)*
Correlation to third year’s sample 0.806 (<0.0001)** – –
Correlation to fifth year’s sample 0.817 (<0.0001)** 0.845 (<0.0001)** –
 * median (interquartile range);
** Spearman rank correlation coefficient (p)
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Stability of anti-Hsp60 autoantibodies during 5 years
Forty-eight subjects recruited into the Second Northwick Park Heart Study who remained 
disease free during follow-up with available stored samples were included into our study. 
Baseline and two follow-up serum samples (years 3 and 5) were studied for the presence 
of specific anti-Hsp60 IgG antibodies. As presented in Table II, median anti-Hsp60 level 
in the baseline sample was 62.4 AU/ml and this level did not significantly change during the 
follow up (53.5 and 51.6 AU/ml, respectively in years 3 and 5; p=0.44, Friedman test). There 
were highly significant correlations between autoantibody levels measured in the three points 
of time (Table II). Figure 2 shows antibody levels in subgroups of subjects stratified into 
quartiles according to baseline concentrations. As presented, those who belong to the low, 
respectively, high concentration groups at the start of the study belong to the same groups 
at the end of the follow-up. There are no changes or crossings between the groups during 
follow up (p>0.05 for each of the subgroups).
Fig. 2. Changes in anti-Hsp60 autoantibody levels in healthy men during five years of follow-up 
Data are presented as means with SEM of the groups
Discussion
In this study anti-human Hsp60 autoantibodies were investigated in a mouse IgM hybridoma 
panel and in samples of healthy subjects whether they bear some characteristics of natural 
autoantibodies. Polyreactivity of IgM clones of newborn mice, presence of IgM anti-Hsp60 
autoantibodies in cord blood of healthy human infants and life-long stability of these 
autoantibodies in healthy adults were investigated. All of these traits are characteristic for 
anti-Hsp60 autoantibodies as shown here for the first time. 
The first novel observation of this study is that a panel of unselected polyreactive IgM 
antibodies of newborn healthy mice contains antibodies reacting with Hsp60 as well. This 
panel was investigated for its reactivity against BSA, actin, DNA and different haptens, and 
the vast majority of the clones have been shown to be polyreactive (20). Specific reactivity 
towards Hsp60 was, however, not examined for these or other natural autoantibodies earlier. 
Importantly, those IgM antibodies showing reactivities against at least 4 antigens or haptens 
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were found to be reactive against Hsp60. Furthermore, Pashov and co-workers revealed 
evidence that actin-purified polyreactive autoantibodies representing the natural autoantibody 
repertoire, also reacted with Hsp90 (22). Thus, our novel observations and the literature data 
support the conclusion that natural autoantibodies in mice contain anti-Hsp60 antibodies and 
these are characterized by polyreactivity. 
The second novel observation of the present study is the description of antibodies against 
human and M. bovis 60 kDa Hsp in cord blood samples of healthy newborns and in their 
mothers. In all of the investigated cord blood samples the presence of significant amounts of 
IgM anti-Hsp60 antibodies was shown. Since none of the babies or their mothers suffered from 
any illness, these antibodies may be considered as natural autoantibodies. Notably is the fact 
that levels of IgM anti-Hsp60 did not correlate to maternal IgM anti-Hsp60 concentrations. 
Since IgM antibodies do not cross the placenta in human this observation strongly supports 
our conclusion that the IgM repertoire of healthy human newborns contains anti-Hsp60 
antibodies and this immunological compartment is independent from the mother’s IgM pool. 
Anti-Hsp65 IgM antibodies were present in much lower titers in the cord blood samples and 
were absent from maternal sera. Although high level of amino-acid similarity exists between 
Hsp60 and Hsp65 convincing evidence suggest that important differences are also present in 
their epitope structure (23, 24). Antibodies reacting with Hsp65 represent mainly serological 
signs of different infections and are induced by molecular mimicry (25). Thus, our results on 
the lack of significant anti-Hsp65 IgM in mothers confirm the proper patient selection process 
including complication-free pregnancies only. The IgG anti-Hsp60 pool may also contain 
natural autoantibodies both in the mother and in the newborn, however, since IgG cross 
the placenta, the independent nature of the infant and maternal immunological compartments 
can not be investigated in these samples. 
According to the third aim of the study changes in anti-Hsp60 levels over a long 
observation period was investigated. A large collection of control serum samples from the 
Second Northwick Park Heart study was applied for this experiment. Anti-Hsp60 IgG levels 
were correlating in three different time points measured during the 5-year long follow-
up period. Those who had low, respectively, high anti-Hsp60 IgG levels in the first year 
remained in the same strata at the end of the observation period. This observation indicates 
tight regulation of IgG anti-Hsp60 autoantibody levels in healthy adults which is in complete 
accordance with our earlier results indicating independence of these autoantibodies from 
serological signs of different infections (19). Our results document the stability of IgG 
antibody reactivity directed toward the conserved Hsp60 through an observation period of 
five years. Similarly, Lacroix-Desmazes et al. (15) observed stability of the natural self-
reactive IgM and IgG antibody repertoires with aging supporting the view that autoreactive B 
cells in the normal immune system are positively selected for reactivity with a limited set of 
immunodominant self-antigens throughout life. Our results indicate that Hsp60 also belong 
to this limited set of dominant self-antigens. Although autoantibody levels against conserved 
proteins remained stable with age, large inter-individual differences were observed with 
regard to reactivities (26). Our data indicate that IgG reactivity toward Hsp60 may also be 
characteristic for a given individual as well, which is consistent with the findings of Lacroix-
Desmazes et al. (14) about the specificity of self-reactive antibody repertoire and with the 
concept of “antibody finger-printing” initially proposed by Francoeur (27).
Based on our earlier and current results together with literature data we propose that 
atherosclerosis associated anti-Hsp60 antibodies may originate from two strongly related 
sources. First, multiple and repeated infections may induce anti-Hsp60 antibodies cross 
reacting between microbial and human antigens. Second, anti-Hsp60 antibodies are present in 
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the natural autoantibody repertoire as well and the size and quality of this repertoire is under 
control of genetic and environmental factors. The environmental control is mainly related to 
the cumulative effect of infections and this is why the two sources of anti-Hsp60 antibodies are 
strongly related. The size of the repertoire, i.e. the large inter-individual differences, is probably 
under the strict control and regulation of genetic factors. Our first observation obtained in 
a healthy Finnish population identified promoter polymorphism of interleukin-6 as one of the 
underlying regulatory factors (17), and these results were confirmed in a recent independent 
study (28). Furthermore, epistatic interaction between immunoglobulin GM allotypes and 
interleukin-6 was also identified in association with increased anti-Hsp60 antibody levels. 
Therefore we suggest that the carriage of high anti-Hsp60 autoantibody levels (as part 
of the natural autoantibody repertoire) may be an inherited trait and the cumulative antibody 
inducing effects of multiple infections add to this trait. After understanding this relationship 
we will be able to estimate atherosclerosis risk early, in neonates or during childhood.
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